On Friday, November 15, 2024, the Drug Enforcement Administration (“DEA”) and the Department of Health and Human Services (“HHS,” and together with the DEA, the “Agencies”) issued a third temporary rule (the “Third Temporary Rule”) extending the COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (“telemedicine flexibilities”). As a result of both Congressional and... READ MORE
DEA and HHS Announce Third Extension of COVID-Era Telemedicine Flexibilities for Controlled Substance Prescribing
Posted on November 20, 2024 in Health Law News
Published by: Hall Render
